CBIC Implements 55th GST Council Recommendation: GST Exemption on Gene Therapy

The CBIC has implemented the 55th GST Council recommendation, granting GST exemption on gene therapy. This move is aimed at promoting innovation in healthcare and making advanced medical treatments more accessible to patients. By exempting gene therapy from GST, the government seeks to encourage research and development in this emerging field, supporting the growth of the biotechnology sector. This initiative reflects a proactive approach to healthcare advancement, ensuring that patients can benefit from cutting-edge treatments without the added financial burden of taxation. The exemption signifies a commitment to fostering innovation while prioritizing public health.